This is a preview of subscription content, log in via an institution to check access.
Reference
Rico-Alba I, et al. The evolution of Reference Drug Lists and Clinical Practice Guidelines in the public health system of a middle-income country. British Journal of Clinical Pharmacology 78: 410-21, No. 2, Aug 2014. Available from: URL: http://doi.org/10.1111/bcp.12337
Rights and permissions
About this article
Cite this article
Most new drugs on the Mexican Reference Drug List "redundant". PharmacoEcon Outcomes News 710, 18 (2014). https://doi.org/10.1007/s40274-014-1491-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1491-x